Cargando…

Identification of MAP3K15 as a potential prognostic biomarker and correlation with immune infiltrates in osteosarcoma

BACKGROUND: Osteosarcoma (OS) is a type of primary malignant tumor, and increasing evidence shows the clinical benefits of immunotherapy in treating OS. However, the lack of comprehensive studies on the complex OS immune microenvironment hinders the application of immunotherapy. Thus, this study aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhuning, Kong, Haoran, Cai, Zhaopeng, Chen, Keng, Wu, Boyang, Li, Haonan, Wang, Peng, Wu, Yanfeng, Shen, Huiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350644/ https://www.ncbi.nlm.nih.gov/pubmed/34430620 http://dx.doi.org/10.21037/atm-21-3181

Ejemplares similares

CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis
por: Kong, Haoran, et al.
Publicado: (2021)

Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis
por: Kong, Haoran, et al.
Publicado: (2022)

Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma
por: Yang, Bingsheng, et al.
Publicado: (2021)

PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
por: Yao, Feng, et al.
Publicado: (2021)

ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
por: Li, Hongyu, et al.
Publicado: (2021)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15
por: Jiang, Jie, et al.
Publicado: (2023)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
por: Zamborsky, Radoslav, et al.
Publicado: (2019)

EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis
por: Dai, Zhenlin, et al.
Publicado: (2023)

Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
por: Chen, Ying, et al.
Publicado: (2020)

Whole Genome Expression Profiling and Signal Pathway Screening of MSCs in Ankylosing Spondylitis
por: Li, Yuxi, et al.
Publicado: (2014)

The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy
por: Wang, Zhanchao, et al.
Publicado: (2021)

KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma
por: Jiang, Yuhang, et al.
Publicado: (2021)

Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning
por: Ji, Yuqiao, et al.
Publicado: (2023)

Identification of LTF as a Prognostic Biomarker for Osteosarcoma
por: Liu, Xiaoqi, et al.
Publicado: (2022)

MAP3K8 Is a Prognostic Biomarker and Correlated With Immune Response in Glioma
por: Ren, Jing, et al.
Publicado: (2021)

Aberrantly Expressed lncRNAs and mRNAs of Osteogenically Differentiated Mesenchymal Stem Cells in Ossification of the Posterior Longitudinal Ligament
por: Cai, Zhaopeng, et al.
Publicado: (2020)

ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer
por: Zhang, Junchang, et al.
Publicado: (2022)

MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma
por: Xu, Shi-hong, et al.
Publicado: (2014)

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016)

Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma
por: Yu, Yiyang, et al.
Publicado: (2020)

TREM2 as a Prognostic Biomarker for Osteosarcoma Microenvironment Remodeling
por: Shen, Zhi-Long, et al.
Publicado: (2023)

Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma
por: Liu, Jian-Dong, et al.
Publicado: (2016)

Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes
por: Guo, Junjie, et al.
Publicado: (2021)

CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2023)

Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration
por: Fu, Yucheng, et al.
Publicado: (2022)

Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration
por: Chen, Zhihao, et al.
Publicado: (2022)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
por: Tang, Zhaopeng, et al.
Publicado: (2021)

Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
por: He, Chuan, et al.
Publicado: (2022)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Hou, Weiyan, et al.
Publicado: (2022)

Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma
por: Wang, Li, et al.
Publicado: (2021)

Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer
por: Chen, Wan-Yu, et al.
Publicado: (2018)

Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer
por: Chen, Yuanmei, et al.
Publicado: (2022)

Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis
por: Wenhui, Yu, et al.
Publicado: (2022)

SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer
por: Li, Jing, et al.
Publicado: (2022)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5cfu5ac1vdskr5kns9i2vahq1